Leonid Timashev
Stock Analyst at RBC Capital
(4.80)
# 495
Out of 4,345 analysts
428
Total ratings
55.7%
Success rate
19.7%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics | Maintained: Buy | $14 → $20 | $11.10 | +80.18% | 23 | May 18, 2026 | |
| CRMD CorMedix | Rated: Buy | $14 | $8.46 | +65.48% | 14 | May 14, 2026 | |
| JSPR Jasper Therapeutics | Maintained: Hold | $4 → $3 | $0.9024 | +232.45% | 7 | May 14, 2026 | |
| PYXS Pyxis Oncology | Maintained: Buy | $5 | $1.73 | +189.02% | 16 | May 14, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $21 → $22 | $11.85 | +85.65% | 16 | May 13, 2026 | |
| ALKS Alkermes | Maintained: Buy | $44 → $45 | $38.09 | +18.14% | 19 | May 12, 2026 | |
| LEGN Legend Biotech | Rated: Buy | $62 → $64 | $28.50 | +124.56% | 42 | May 12, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $14 | $4.16 | +236.54% | 9 | May 11, 2026 | |
| ADCT ADC Therapeutics | Maintained: Buy | $6 | $3.43 | +74.93% | 14 | May 8, 2026 | |
| CGON CG Oncology | Rated: Buy | $79 → $81 | $60.80 | +33.22% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 → $205 | $106.40 | +92.67% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.25 | +252.94% | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $33.54 | +49.08% | 37 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $50.03 | -14.05% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $195 → $258 | $237.56 | +8.60% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $423 → $425 | $300.01 | +41.66% | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $162 → $165 | $153.00 | +7.84% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $36.54 | +28.64% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $119 | $77.15 | +54.24% | 21 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $11.72 | +62.12% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $242 → $302 | $234.52 | +28.77% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $29.28 | +81.01% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.74 | +321.94% | 10 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $11.29 | +94.86% | 28 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $4.57 | +9.41% | 4 | Apr 30, 2026 |
Design Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $11.10
Upside: +80.18%
CorMedix
May 14, 2026
Rated: Buy
Price Target: $14
Current: $8.46
Upside: +65.48%
Jasper Therapeutics
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.9024
Upside: +232.45%
Pyxis Oncology
May 14, 2026
Maintained: Buy
Price Target: $5
Current: $1.73
Upside: +189.02%
COMPASS Pathways
May 13, 2026
Maintained: Buy
Price Target: $21 → $22
Current: $11.85
Upside: +85.65%
Alkermes
May 12, 2026
Maintained: Buy
Price Target: $44 → $45
Current: $38.09
Upside: +18.14%
Legend Biotech
May 12, 2026
Rated: Buy
Price Target: $62 → $64
Current: $28.50
Upside: +124.56%
Perspective Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $14
Current: $4.16
Upside: +236.54%
ADC Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $6
Current: $3.43
Upside: +74.93%
CG Oncology
May 8, 2026
Rated: Buy
Price Target: $79 → $81
Current: $60.80
Upside: +33.22%
May 7, 2026
Maintained: Buy
Price Target: $220 → $205
Current: $106.40
Upside: +92.67%
May 7, 2026
Maintained: Buy
Price Target: $15
Current: $4.25
Upside: +252.94%
May 7, 2026
Maintained: Buy
Price Target: $50
Current: $33.54
Upside: +49.08%
May 6, 2026
Maintained: Hold
Price Target: $43
Current: $50.03
Upside: -14.05%
May 6, 2026
Rated: Buy
Price Target: $195 → $258
Current: $237.56
Upside: +8.60%
May 6, 2026
Maintained: Buy
Price Target: $423 → $425
Current: $300.01
Upside: +41.66%
May 6, 2026
Maintained: Buy
Price Target: $162 → $165
Current: $153.00
Upside: +7.84%
May 6, 2026
Maintained: Buy
Price Target: $47
Current: $36.54
Upside: +28.64%
May 5, 2026
Maintained: Buy
Price Target: $101 → $119
Current: $77.15
Upside: +54.24%
May 5, 2026
Maintained: Buy
Price Target: $19
Current: $11.72
Upside: +62.12%
May 5, 2026
Maintained: Buy
Price Target: $242 → $302
Current: $234.52
Upside: +28.77%
May 5, 2026
Maintained: Buy
Price Target: $53
Current: $29.28
Upside: +81.01%
May 4, 2026
Maintained: Buy
Price Target: $20
Current: $4.74
Upside: +321.94%
May 4, 2026
Rated: Buy
Price Target: $23 → $22
Current: $11.29
Upside: +94.86%
Apr 30, 2026
Maintained: Hold
Price Target: $7 → $5
Current: $4.57
Upside: +9.41%